Patients With Tuberculosis at Increased Risk of Gout
HCPLive
MARCH 26, 2025
Other risk factors in the population included PZA or ETB use, hypertension, heart failure, and chronic kidney disease.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
HCPLive
MARCH 26, 2025
Other risk factors in the population included PZA or ETB use, hypertension, heart failure, and chronic kidney disease.
American College of Cardiology
FEBRUARY 5, 2024
Hypertension represents a major modifiable risk factor for coronary artery disease (CAD), heart failure (HF), stroke, chronic kidney disease (CKD), and dementia.
MIBHS
FEBRUARY 15, 2025
High blood pressure, also known as hypertension, is a common condition that affects millions of people worldwide. Often referred to as the silent killer, hypertension can quietly damage your heart and other vital organs over time. Hypertension is diagnosed when blood pressure consistently reads 130/80 mm Hg or higher.
Circulation
MARCH 9, 2025
Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors. Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025.
Open Heart
JUNE 1, 2022
Objectives We aim to assess the association of cardiovascular medications with outcomes of patients referred to the diagnostic heart failure (HF) clinic with symptoms or signs of possible HF, raised N-terminal pro-brain-type natriuretic peptide (NT-proBNP) but no evidence of HF on transthoracic echocardiography (TTE). to 0.97; p=0.02).
Heart BMJ
OCTOBER 10, 2024
The association between AF and various conditions—including hypertension, heart failure, sleep apnoea and chronic kidney disease—is well-described, highlighting that AF is often a multisystem disorder. 2 Before the.
Circulation: Heart Failure
MARCH 8, 2024
Circulation: Heart Failure, Ahead of Print. Background:Current prevalence estimates of heart failure (HF) are primarily based on self-report or HF hospitalizations. Overt cardiovascular disease, which ranged from 2.1% (HF) to 13.6% (atrial fibrillation), was less common. were female, 25.6% were Black, 12.8%
Cardiometabolic Health Congress
NOVEMBER 16, 2023
Key findings presented at the conference included disparities in access to kidney transplantation and waitlisting based on race and neighborhood characteristics, racial and ethnic differences in incident chronic kidney disease (CKD), and the use of motivational strategies to improve dialysis nonadherence among African American patients.
Circulation
NOVEMBER 11, 2024
Patients with hyperkalemia had a higher frequency of diabetes mellitus, hypertension, chronic liver disease, acute kidney injury, chronic kidney disease, end-stage renal disease, and acute encephalopathy (p<0.001).
Hypertension Journal
DECEMBER 12, 2023
Hypertension, Ahead of Print. Failure of this process is a hallmark of hypertension, chronic kidney disease, heart failure, and other acute and chronic diseases. Homeostasis of fluid and electrolytes is a tightly controlled physiological process.
Journal of the American Heart Association
MARCH 27, 2025
Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovascular disease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovascular disease and smoking); (..)
European Journal of Heart Failure
NOVEMBER 23, 2023
Abstract Aims Transthyretin cardiac amyloidosis (ATTR-CA) is an infiltrative cardiomyopathy that commonly presents with concomitant chronic kidney disease. Albuminuria is common in heart failure and associated with worse outcomes, but its prevalence and relationship to outcome in ATTR-CA remains unclear.
Stroke Journal
JANUARY 30, 2025
Propensity score-matched analysis (PSM) (1:1) was performed on age, gender, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, LDL level, left ventricular ejection fraction and various drugs including beta blockers, ACEi and ARBi. The mean age of patients was comparable between both groups (59.8
Circulation
NOVEMBER 11, 2024
He was counseled to abstain from cannabis use.Conclusion:At low to moderate doses, cannabis can lead to a surge in sympathetic activity causing tachycardia and hypertension, while parasympathetic activity is predominant at higher doses, causing bradycardia and hypotension. Patient did not report any symptoms and was hemodynamically stable.
Stroke Journal
JANUARY 30, 2025
Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.
Stroke Journal
FEBRUARY 1, 2024
Regarding comorbidities, congestive heart failure (OR 1.73, p <0.01, CI 1.32 to 2.26) and liver disease (OR 2.20, p < 0.01, CI 1.27 Regarding comorbidities, congestive heart failure (OR 1.73, p <0.01, CI 1.32 to 2.26) and liver disease (OR 2.20, p < 0.01, CI 1.27
DAIC
MARCH 26, 2025
Food and Drug Administration (FDA) accepted its supplemental new drug application (sNDA) and granted Priority Review designation for KERENDIA(finerenone) for the treatment of adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF).
DAIC
JANUARY 19, 2024
The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications. Orchestra BioMed and Medtronic, Inc. Kowal, M.D., and Europe.
Open Heart
JULY 6, 2023
Background Chronic kidney disease (CKD) and atrial fibrillation (AF) are increasing in prevalence globally and share common risk factors. Age, sex, diabetes, hypertension and heart failure were chosen as variables of interest. Methods PubMed, EMBASE and CINAHL were searched from inception to June 2022.
CardiacWire
OCTOBER 27, 2024
It’s well known that heart disease is the U.S.’s s top cause of death, and our rising CVD rates have been widely covered, but a look back on some of the biggest stories of 2024 suggests that cardiovascular disease is about to become a much bigger problem. Hypertension Problems: Another JAMA study highlighted the U.S.’s
DAIC
SEPTEMBER 11, 2024
Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 million U.S. adults, according to new estimates from University of California-San Francisco. Earlier projections had estimated that 3.3
Open Heart
JANUARY 13, 2023
Objectives Accurate prediction of heart failure (HF) patients at high risk of atrial fibrillation (AF) represents a potentially valuable tool to inform shared decision making. No validated prediction model for AF in HF is currently available. The objective was to develop clinical prediction models for 1-year risk of AF.
Hypertension Journal
OCTOBER 11, 2023
Hypertension, Volume 80, Issue 12 , Page 2591-2600, December 1, 2023. RESULTS:The median age of the patients was 76 years, and 54.9% were women. The total AHT incidence was 70 cases per 100 000 admission year. Urgent dialysis rates increased from 1.52% (95% CI, 1.12–2.06) 2.06) to 2.60% (2.17–3.1;
Journal of the American Heart Association
JANUARY 23, 2024
BackgroundThe relation between age at diagnosis of type 2 diabetes (T2D) and hospitalization for heart failure (HHF) is unclear. Additional adjustment for mediators (hypertension, coronary artery disease, and chronic kidney disease) marginally attenuated this relationship.
Cardiometabolic Health Congress
AUGUST 8, 2024
Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g., Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,
Frontiers in Cardiovascular Medicine
FEBRUARY 13, 2024
By comparing myocardial injury patients with non-myocardial injury patients, notable differences were observed in age, pre-existing medical conditions (e.g.,
Cardiometabolic Health Congress
SEPTEMBER 13, 2024
New guidelines also: Classify “Elevated BP” between non-elevated BP and hypertension. Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Advise increased potassium intake for hypertensive patients. FINEARTS Trial: Prof.
Circulation
NOVEMBER 11, 2024
The diagnosis of hypertension is associated with a significant increase in the risk of kidney or cardiovascular events, with no prior history of these events. Total deaths from hypertensive heart disease and renal disease associated with heart failure were 5,274, showing an increasing trend from 1999 to 2020.
DAIC
SEPTEMBER 11, 2024
Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 million U.S. adults, according to new estimates from University of California-San Francisco. Earlier projections had estimated that 3.3
Cardiometabolic Health Congress
JULY 25, 2023
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] Is the obesity paradox a real phenomenon?
All About Cardiovascular System and Disorders
OCTOBER 25, 2023
AF-CHF trial in those with AF and congestive heart failure also failed to show any advantage for the rhythm control strategy [3]. Overall, it appears that rhythm control strategy in AF may be better in those with heart failure and in those with associated cardiovascular conditions and early AF.
Journal of the American Heart Association
MARCH 21, 2025
Prevalence of hypertension (86.6%), heart failure (22.7%), diabetes (54.8%), chronic kidney disease (23.6%), and chronic obstructive pulmonary disease (35.4%) was high. The mean anklebrachial index value was 0.78 (SD: 0.26) and the mean toebrachial index value was 0.51 (SD: 0.19). At 1 year, 9.4%
Circulation: Cardiovascular Imaging
JANUARY 15, 2024
BACKGROUND:Advanced chronic kidney disease is associated with high cardiovascular risk, even after kidney transplant. METHODS:We retrospectively followed patients who underwent MPI before kidney transplant for the occurrence of MACE after transplant including myocardial infarction, stroke, heart failure, and cardiac death.
Stroke Journal
FEBRUARY 1, 2024
FD residents were significantly more likely to have comorbid hypertension (OR 1.14, 95%CI 1.09, 1.19), type 2 diabetes (OR 1.21, 95%CI 1.17, 1.25), heart failure (OR 1.14, 95%CI 1.09, 1.19), and chronic kidney disease (OR 1.24, 95%CI 1.18, 1.30) associated with acute stroke hospital admission.
European Journal of Heart Failure
DECEMBER 12, 2023
Background Anemia and ID are common comorbidities in cardiovascular patients and are associated with a poor clinical status, as well as a worse outcome in patients with heart failure and AMI. Nevertheless, data concerning the impact of anemia and ID on clinical outcome in patients with CS are scarce.
Cardiometabolic Health Congress
JUNE 29, 2023
On Aug. (..)
Circulation
NOVEMBER 16, 2023
1.23]), hypertension (adjusted HR, 2.01 [95% CI, 1.57–2.57]), 2.57]), chronic kidney disease (adjusted HR, 1.68 [95% CI, 1.36–2.09]), 2.15]), heart failure (adjusted HR, 1.51 [95% CI, 1.16–1.95]), Clinical factors associated with higher mortality included male sex (adjusted HR, 1.31 [95% CI, 1.08–1.58]),
Physiologically Speaking
DECEMBER 15, 2023
Resistance exercise also appears to be safe and effective for adults with heart failure, peripheral arterial disease (PAD), HIV, Alzheimer’s disease and dementia, and chronic kidney disease, among other conditions — for whom the benefits are likely much greater than those for adults without known diseases.
Physiologically Speaking
DECEMBER 15, 2023
Resistance exercise also appears to be safe and effective for adults with heart failure, peripheral arterial disease (PAD), HIV, Alzheimer’s disease and dementia, and chronic kidney disease, among other conditions — for whom the benefits are likely much greater than those for adults without known diseases.
Dr. Smith's ECG Blog
APRIL 8, 2016
He also had a history of chronic kidney disease, stage III. Angio had shown some acute disease in the saphenous vein graft to the posterior descending artery off of the RCA. Heart failure leading to death was related to all subclasses of PVC. Most recent echo showed EF of 60%. He had recently had a NonSTEMI.
Cardiometabolic Health Congress
DECEMBER 7, 2023
AF is associated with an increased risk of death as well as multiple adverse outcomes, including stroke, cognitive impairment or dementia, myocardial infarction, sudden cardiac death, heart failure (HF), chronic kidney disease (CKD), and peripheral artery disease (PAD).
Frontiers in Cardiovascular Medicine
DECEMBER 20, 2024
CVD included stroke, congestive heart failure, coronary heart disease, and angina. Compared with participants without asthma, the prevalence of stroke in those with asthma was increased by 1.607 times; the prevalence of congestive heart failure was increased by 1.911 times.
Cardiometabolic Health Congress
NOVEMBER 14, 2024
Cardiovascular disease remains the leading cause of death worldwide , claiming 18 million lives annually. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. In the U.S.,
Dr. Smith's ECG Blog
FEBRUARY 26, 2025
Mechanical complications such as free wall rupture, VSR and papillary muscle rupture is more likely to occur in patients who are older, female, hypertensive, have chronic kidney disease, and have no prior history of smoking. The patient was not considered a surgical candidate. Physical Exam was revealing.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content